Alan Brochstein
shared:
9/28/2017 7:16:38 AM
ReplyZynerba Synthetic CBD Gel Fragile X Syndrome Phase 2 Trial Succeeds https://t.co/p0apXqvoiF $ZYNE #CBD #FragileX
— Alan Brochstein, CFA (@Invest420) September 28, 2017
